Triple-negative breast cancer, which affects between 15% and 20% of breast cancer patients, is a highly aggressive cancer that does not respond to conventional hormonal therapy. In this interview with naturopathic oncology specialist Adam Kerievsky, ND, LAc, FABNO, we discuss the risk factors for this disease, the treatment challenges it poses for practitioners, and complementary therapies that may benefit patients battling this cancer.
Approximate listening time: 14 minutes
About the Expert
Adam Kerievsky, ND, LAc, FABNO, earned his doctorate of naturopathic medicine and his certification in acupuncture from the Southwest College of Naturopathic Medicine in Tempe, Arizona. He is also a diplomate of the American Academy of Pain Management and joined Cancer Treatment Centers of America in 2009.
About the Sponsor
Cancer Treatment Centers of America (CTCA) is a national network of hospitals providing a comprehensive, fully integrated approach to cancer treatment. CTCA serves patients with complex cancer from all 50 states at facilities located in suburban Phoenix, suburban Chicago, suburban Atlanta, Philadelphia, and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowerment Medicine®, CTCA provides patients with information about cancer and their treatment options so they can control their treatment decisions. For more information about CTCA, visit www.cancercenter.com.